Results of Operations
We have neither engaged in any operations nor generated any operating revenues to date. Our only activities for the period from February 3, 2021 (inception) through December 31, 2021 and for the year ended December 31, 2022 were organizational activities, those necessary to prepare for the initial public offering, as described below, and since the closing of the initial public offering, the search for a prospective initial business combination. We will not be generating any operating revenues until the closing and completion of our initial business combination, at the earliest. We generate non-operating income in the form of interest income on cash and cash equivalents held after the initial public offering. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as due diligence expenses.
For the year ended December 31, 2022, we had a net income of $1,059,800 which resulted from a gain on investments held in the Trust Account of $2,542,494, offset by formation and operating costs of $1,452,694 and a loss on sale of private placement warrants of $30,000.
For the period from February 3, 2021 (inception) through December 31, 2021, we had a net loss of $482,997, which resulted from formation and operating costs of $139,479, loss on sale of private placement warrants of $343,999, offset in part by unrealized gain on investments held in Trust Account in the amount of $311 and realized gain on investments held in Trust Account of $170.
Liquidity, Capital Resources and Going Concern
As of December 31, 2022, the company had cash held outside of the Trust Account of $461,914 and a working capital surplus of $63,250.
Our liquidity needs up to December 31, 2022 had been satisfied through a payment of $25,000 from the sponsor to cover certain expenses on behalf of the company in exchange for the issuance of the founder shares, a loan under the promissory note from our sponsor of approximately $149,172, and the net proceeds from the consummation of the private placement not held in the Trust Account. The promissory note was repaid in full on December 21, 2021. In addition, in order to finance transaction costs in connection with an initial business combination, our officers, directors and initial shareholders may, but are not obligated to, provide the company with working capital loans. To date, there are no amounts outstanding under any working capital loans.
For the year ended December 31, 2022, net cash used in operating activities was $413,917, which was due to our net income of $1,059,800 and a gain on investments held in the Trust Account of $2,542,494, offset in part by changes in working capital of $938,585 and a loss on the sale of private placement warrants to our sponsor of $30,000.
For the period from February 3, 2021 (inception) through December 31, 2021, net cash used in operating activities was $1,099,296, which was due to net loss of $482,997, realized gain on investments held in the Trust Account of $311, unrealized gain on investments held in the Trust Account of $170 and changes in working capital of $959,817, offset in part by a non-cash loss on the sale of private placement warrants of $343,999.
For the year ended December 31, 2022, net cash used in investing activities of $25,250,000 was the result of the amount of net proceeds from the exercise of the Over-Allotment Option being deposited to the Trust Account.
For the period from February 3, 2021 (inception) through December 31, 2021, net cash used in investing activities of $202,000,000 was the result of the amount of net proceeds from the closing of our initial public offering being deposited to the Trust Account.
For the year ended December 31, 2022, net cash provided by financing activities of $25,250,0000 was comprised of $24,500,000 in proceeds from the initial public offering net of underwriting discount paid and $750,000 in proceeds from the sale of private placement warrants.
For the period from February 3, 2021 (inception) through December 31, 2021, net cash provided by financing activities of $203,975,127 was comprised of $196,000,000 in proceeds from the initial public offering net of underwriting discount paid, $8,600,000 in proceeds from the sale of private placement warrants, $25,000 in proceeds from the issuance of Class B ordinary shares to sponsor and $6,750 in proceeds from the issuance of Class B ordinary shares to anchor investors, partially offset by the payment of $656,623 for offering costs associated with the initial public offering.
59